(720 ILCS 570/203) (from Ch. 56 1/2, par. 1203)
    Sec. 203. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule I if it finds that:
        (1) the substance has high potential for misuse; and
        (2) the substance has no currently accepted medical
    
use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.
(Source: P.A. 103-881, eff. 1-1-25.)